|
ZNF594 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.098790E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.830200E-01 |
| Normal-vs-Stage2 |
4.918600E-01 |
| Normal-vs-Stage3 |
4.569200E-01 |
| Normal-vs-Stage4 |
1.385040E-01 |
| Stage1-vs-Stage2 |
8.750800E-01 |
| Stage1-vs-Stage3 |
1.533390E-01 |
| Stage1-vs-Stage4 |
1.188200E-01 |
| Stage2-vs-Stage3 |
2.375200E-01 |
| Stage2-vs-Stage4 |
1.721400E-01 |
| Stage3-vs-Stage4 |
4.595600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.036100E-02 |
| Normal-vs-AfricanAmerican |
4.741000E-01 |
| Normal-vs-Asian |
1.217370E-01 |
| Caucasian-vs-AfricanAmerican |
4.190400E-01 |
| Caucasian-vs-Asian |
1.380590E-01 |
| AfricanAmerican-vs-Asian |
1.869200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.277570E-01 |
| Normal-vs-Female |
2.097000E-01 |
| Male-vs-Female |
9.132800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.851200E-01 |
| Normal-vs-Extreme_Weight |
6.459400E-01 |
| Normal-vs-Obese |
6.347600E-02 |
| Normal-vs-Extreme_Obese |
4.276200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.018600E-01 |
| Normal_Weight-vs-Obese |
1.336160E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.022600E-01 |
| Extreme_Weight-vs-Obese |
1.383390E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.118000E-01 |
| Obese-vs-Extreme_Obese |
6.902800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.795590E-01 |
| Normal-vs-Age(41-60Yrs) |
1.407850E-02 |
| Normal-vs-Age(61-80Yrs) |
5.304400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.562400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.978600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.989000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.072840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.318400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.008300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.220790E-03 |
| Normal-VS-Type2 PRCC |
1.534080E-02 |
| Normal-VS-KIRP CIMP |
4.461400E-01 |
| Normal-VS-Unclassified PRCC |
1.345010E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.6647017098137E-11 |
| Type1 PRCC-VS-KIRP CIMP |
2.718300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.068000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.538600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.022700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.173830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.035400E-01 |
| Normal-vs-N1 |
3.129400E-01 |
| Normal-vs-N2 |
9.836100E-03 |
| N0-vs-N1 |
1.107350E-01 |
| N0-vs-N2 |
6.135800E-02 |
| N1-vs-N2 |
7.296500E-02 |
|
|
